nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLCO2B1—Erlotinib—lung cancer	0.151	0.4	CbGbCtD
Niacin—SLC16A1—Methotrexate—lung cancer	0.115	0.304	CbGbCtD
Niacin—CYP2D6—Gefitinib—lung cancer	0.0356	0.0945	CbGbCtD
Niacin—CYP2D6—Vinorelbine—lung cancer	0.0274	0.0728	CbGbCtD
Niacin—CYP2D6—Erlotinib—lung cancer	0.021	0.0559	CbGbCtD
Niacin—CYP2D6—Vinblastine—lung cancer	0.0169	0.0449	CbGbCtD
Niacin—CYP2D6—Doxorubicin—lung cancer	0.0104	0.0276	CbGbCtD
Niacin—HCAR2—respiratory system—lung cancer	0.0101	0.0992	CbGeAlD
Niacin—NNMT—mammary gland—lung cancer	0.00853	0.0837	CbGeAlD
Niacin—HCAR3—lung—lung cancer	0.0081	0.0795	CbGeAlD
Niacin—NNMT—respiratory system—lung cancer	0.00569	0.0558	CbGeAlD
Niacin—HCAR2—lung—lung cancer	0.00537	0.0527	CbGeAlD
Niacin—NNMT—bronchus—lung cancer	0.00468	0.0459	CbGeAlD
Niacin—SLC16A3—Azacitidine—Gemcitabine—lung cancer	0.00427	1	CbGdCrCtD
Niacin—NNMT—trachea—lung cancer	0.0042	0.0412	CbGeAlD
Niacin—NNMT—cardiac atrium—lung cancer	0.00395	0.0387	CbGeAlD
Niacin—SLC16A3—respiratory system—lung cancer	0.00388	0.0381	CbGeAlD
Niacin—HCAR2—lymph node—lung cancer	0.00367	0.036	CbGeAlD
Niacin—Metyrapone—ABCC3—lung cancer	0.00356	0.341	CrCbGaD
Niacin—NNMT—bone marrow—lung cancer	0.00333	0.0327	CbGeAlD
Niacin—SLC16A3—epithelium—lung cancer	0.00325	0.0319	CbGeAlD
Niacin—SLC16A3—bronchus—lung cancer	0.0032	0.0314	CbGeAlD
Niacin—SLCO2B1—mammary gland—lung cancer	0.00305	0.0299	CbGeAlD
Niacin—NNMT—lung—lung cancer	0.00302	0.0296	CbGeAlD
Niacin—SLC16A3—trachea—lung cancer	0.00287	0.0282	CbGeAlD
Niacin—Salicylic acid—AKR1C1—lung cancer	0.0028	0.268	CrCbGaD
Niacin—SLC16A3—bone marrow—lung cancer	0.00228	0.0223	CbGeAlD
Niacin—NNMT—lymph node—lung cancer	0.00206	0.0203	CbGeAlD
Niacin—SLC16A3—lung—lung cancer	0.00206	0.0202	CbGeAlD
Niacin—SLCO2B1—respiratory system—lung cancer	0.00203	0.0199	CbGeAlD
Niacin—SLC22A5—mammary gland—lung cancer	0.00202	0.0199	CbGeAlD
Niacin—SLC16A1—epithelium—lung cancer	0.00197	0.0194	CbGeAlD
Niacin—Metyrapone—CYP2A6—lung cancer	0.00193	0.185	CrCbGaD
Niacin—SLC16A1—cardiac atrium—lung cancer	0.00164	0.0161	CbGeAlD
Niacin—SLC16A3—lymph node—lung cancer	0.00141	0.0138	CbGeAlD
Niacin—Metyrapone—CYP2E1—lung cancer	0.00137	0.131	CrCbGaD
Niacin—SLC22A5—respiratory system—lung cancer	0.00135	0.0132	CbGeAlD
Niacin—SLC16A1—lung—lung cancer	0.00125	0.0123	CbGeAlD
Niacin—SLC22A5—bronchus—lung cancer	0.00111	0.0109	CbGeAlD
Niacin—SLCO2B1—lung—lung cancer	0.00108	0.0106	CbGeAlD
Niacin—SLC22A5—trachea—lung cancer	0.000996	0.00978	CbGeAlD
Niacin—SLC22A5—cardiac atrium—lung cancer	0.000936	0.00918	CbGeAlD
Niacin—SLC16A1—lymph node—lung cancer	0.000857	0.00841	CbGeAlD
Niacin—SLCO2B1—lymph node—lung cancer	0.000737	0.00723	CbGeAlD
Niacin—SLC22A5—lung—lung cancer	0.000716	0.00702	CbGeAlD
Niacin—SLC22A5—lymph node—lung cancer	0.000489	0.0048	CbGeAlD
Niacin—Salicylic acid—PTGS2—lung cancer	0.000285	0.0273	CrCbGaD
Niacin—Salicylic acid—ALB—lung cancer	0.000254	0.0243	CrCbGaD
Niacin—Salicylic acid—ABCB1—lung cancer	0.000242	0.0232	CrCbGaD
Niacin—Skin disorder—Etoposide—lung cancer	0.000151	0.000522	CcSEcCtD
Niacin—Erectile dysfunction—Methotrexate—lung cancer	0.000151	0.000521	CcSEcCtD
Niacin—Dry skin—Doxorubicin—lung cancer	0.000151	0.000519	CcSEcCtD
Niacin—Hyperhidrosis—Etoposide—lung cancer	0.000151	0.000519	CcSEcCtD
Niacin—Shock—Paclitaxel—lung cancer	0.00015	0.000518	CcSEcCtD
Niacin—Dizziness—Vinorelbine—lung cancer	0.00015	0.000518	CcSEcCtD
Niacin—Orthostatic hypotension—Doxorubicin—lung cancer	0.00015	0.000518	CcSEcCtD
Niacin—Tachycardia—Paclitaxel—lung cancer	0.000149	0.000514	CcSEcCtD
Niacin—Anorexia—Etoposide—lung cancer	0.000149	0.000512	CcSEcCtD
Niacin—Skin disorder—Paclitaxel—lung cancer	0.000149	0.000511	CcSEcCtD
Niacin—Abdominal pain—Irinotecan—lung cancer	0.000148	0.00051	CcSEcCtD
Niacin—Body temperature increased—Irinotecan—lung cancer	0.000148	0.00051	CcSEcCtD
Niacin—Decreased appetite—Cisplatin—lung cancer	0.000148	0.00051	CcSEcCtD
Niacin—Hyperhidrosis—Paclitaxel—lung cancer	0.000148	0.000509	CcSEcCtD
Niacin—Gastrointestinal disorder—Cisplatin—lung cancer	0.000147	0.000506	CcSEcCtD
Niacin—Anorexia—Paclitaxel—lung cancer	0.000146	0.000502	CcSEcCtD
Niacin—Hypotension—Etoposide—lung cancer	0.000146	0.000502	CcSEcCtD
Niacin—Pain—Cisplatin—lung cancer	0.000146	0.000501	CcSEcCtD
Niacin—Muscular weakness—Doxorubicin—lung cancer	0.000145	0.0005	CcSEcCtD
Niacin—Vomiting—Vinorelbine—lung cancer	0.000145	0.000498	CcSEcCtD
Niacin—Body temperature increased—Gemcitabine—lung cancer	0.000144	0.000497	CcSEcCtD
Niacin—Rash—Vinorelbine—lung cancer	0.000143	0.000494	CcSEcCtD
Niacin—Dermatitis—Vinorelbine—lung cancer	0.000143	0.000493	CcSEcCtD
Niacin—Abdominal distension—Doxorubicin—lung cancer	0.000143	0.000493	CcSEcCtD
Niacin—Hypotension—Paclitaxel—lung cancer	0.000143	0.000492	CcSEcCtD
Niacin—Stomatitis—Methotrexate—lung cancer	0.000143	0.000492	CcSEcCtD
Niacin—Headache—Vinorelbine—lung cancer	0.000142	0.00049	CcSEcCtD
Niacin—Syncope—Docetaxel—lung cancer	0.000142	0.00049	CcSEcCtD
Niacin—Influenza—Doxorubicin—lung cancer	0.000142	0.00049	CcSEcCtD
Niacin—Dysphagia—Doxorubicin—lung cancer	0.000142	0.00049	CcSEcCtD
Niacin—Leukopenia—Docetaxel—lung cancer	0.000142	0.000489	CcSEcCtD
Niacin—Sweating—Methotrexate—lung cancer	0.00014	0.000483	CcSEcCtD
Niacin—Palpitations—Docetaxel—lung cancer	0.00014	0.000483	CcSEcCtD
Niacin—Paraesthesia—Etoposide—lung cancer	0.00014	0.000482	CcSEcCtD
Niacin—Loss of consciousness—Docetaxel—lung cancer	0.00014	0.000481	CcSEcCtD
Niacin—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000139	0.00048	CcSEcCtD
Niacin—Dyspnoea—Etoposide—lung cancer	0.000139	0.000479	CcSEcCtD
Niacin—Somnolence—Etoposide—lung cancer	0.000139	0.000477	CcSEcCtD
Niacin—Cough—Docetaxel—lung cancer	0.000139	0.000477	CcSEcCtD
Niacin—Angina pectoris—Doxorubicin—lung cancer	0.000139	0.000477	CcSEcCtD
Niacin—Insomnia—Paclitaxel—lung cancer	0.000138	0.000476	CcSEcCtD
Niacin—Hypersensitivity—Irinotecan—lung cancer	0.000138	0.000476	CcSEcCtD
Niacin—Paraesthesia—Paclitaxel—lung cancer	0.000137	0.000473	CcSEcCtD
Niacin—Bronchitis—Doxorubicin—lung cancer	0.000137	0.000471	CcSEcCtD
Niacin—Dyspnoea—Paclitaxel—lung cancer	0.000136	0.000469	CcSEcCtD
Niacin—Somnolence—Paclitaxel—lung cancer	0.000136	0.000468	CcSEcCtD
Niacin—Decreased appetite—Etoposide—lung cancer	0.000136	0.000467	CcSEcCtD
Niacin—Myalgia—Docetaxel—lung cancer	0.000135	0.000466	CcSEcCtD
Niacin—Arthralgia—Docetaxel—lung cancer	0.000135	0.000466	CcSEcCtD
Niacin—Nausea—Vinorelbine—lung cancer	0.000135	0.000465	CcSEcCtD
Niacin—Gastrointestinal disorder—Etoposide—lung cancer	0.000135	0.000464	CcSEcCtD
Niacin—Dyspepsia—Paclitaxel—lung cancer	0.000135	0.000463	CcSEcCtD
Niacin—Body temperature increased—Cisplatin—lung cancer	0.000135	0.000463	CcSEcCtD
Niacin—Asthenia—Irinotecan—lung cancer	0.000135	0.000463	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000134	0.000462	CcSEcCtD
Niacin—Pain—Etoposide—lung cancer	0.000133	0.000459	CcSEcCtD
Niacin—Decreased appetite—Paclitaxel—lung cancer	0.000133	0.000458	CcSEcCtD
Niacin—Dry mouth—Docetaxel—lung cancer	0.000132	0.000455	CcSEcCtD
Niacin—Haemoglobin—Methotrexate—lung cancer	0.000132	0.000455	CcSEcCtD
Niacin—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000132	0.000455	CcSEcCtD
Niacin—Haemorrhage—Methotrexate—lung cancer	0.000131	0.000453	CcSEcCtD
Niacin—Hepatitis—Methotrexate—lung cancer	0.000131	0.000453	CcSEcCtD
Niacin—Asthenia—Gemcitabine—lung cancer	0.000131	0.000451	CcSEcCtD
Niacin—Pain—Paclitaxel—lung cancer	0.000131	0.00045	CcSEcCtD
Niacin—Anaphylactic shock—Docetaxel—lung cancer	0.00013	0.000446	CcSEcCtD
Niacin—Oedema—Docetaxel—lung cancer	0.00013	0.000446	CcSEcCtD
Niacin—Pruritus—Gemcitabine—lung cancer	0.000129	0.000445	CcSEcCtD
Niacin—Diarrhoea—Irinotecan—lung cancer	0.000128	0.000442	CcSEcCtD
Niacin—Gastrointestinal pain—Etoposide—lung cancer	0.000128	0.000439	CcSEcCtD
Niacin—Shock—Docetaxel—lung cancer	0.000128	0.000439	CcSEcCtD
Niacin—Visual impairment—Methotrexate—lung cancer	0.000127	0.000436	CcSEcCtD
Niacin—Tachycardia—Docetaxel—lung cancer	0.000126	0.000436	CcSEcCtD
Niacin—Skin disorder—Docetaxel—lung cancer	0.000126	0.000433	CcSEcCtD
Niacin—Hypersensitivity—Cisplatin—lung cancer	0.000125	0.000432	CcSEcCtD
Niacin—Gastrointestinal pain—Paclitaxel—lung cancer	0.000125	0.000431	CcSEcCtD
Niacin—Diarrhoea—Gemcitabine—lung cancer	0.000125	0.00043	CcSEcCtD
Niacin—Dizziness—Irinotecan—lung cancer	0.000124	0.000427	CcSEcCtD
Niacin—Urticaria—Etoposide—lung cancer	0.000124	0.000427	CcSEcCtD
Niacin—Stomatitis—Doxorubicin—lung cancer	0.000124	0.000426	CcSEcCtD
Niacin—Jaundice—Doxorubicin—lung cancer	0.000124	0.000426	CcSEcCtD
Niacin—Anorexia—Docetaxel—lung cancer	0.000124	0.000425	CcSEcCtD
Niacin—Abdominal pain—Etoposide—lung cancer	0.000123	0.000424	CcSEcCtD
Niacin—Body temperature increased—Etoposide—lung cancer	0.000123	0.000424	CcSEcCtD
Niacin—Eye disorder—Methotrexate—lung cancer	0.000123	0.000423	CcSEcCtD
Niacin—Tinnitus—Methotrexate—lung cancer	0.000123	0.000422	CcSEcCtD
Niacin—Asthenia—Cisplatin—lung cancer	0.000122	0.000421	CcSEcCtD
Niacin—Sweating—Doxorubicin—lung cancer	0.000122	0.000419	CcSEcCtD
Niacin—Urticaria—Paclitaxel—lung cancer	0.000121	0.000418	CcSEcCtD
Niacin—Hypotension—Docetaxel—lung cancer	0.000121	0.000417	CcSEcCtD
Niacin—Abdominal pain—Paclitaxel—lung cancer	0.000121	0.000416	CcSEcCtD
Niacin—Body temperature increased—Paclitaxel—lung cancer	0.000121	0.000416	CcSEcCtD
Niacin—Angiopathy—Methotrexate—lung cancer	0.000119	0.000411	CcSEcCtD
Niacin—Vomiting—Irinotecan—lung cancer	0.000119	0.00041	CcSEcCtD
Niacin—Rash—Irinotecan—lung cancer	0.000118	0.000407	CcSEcCtD
Niacin—Dermatitis—Irinotecan—lung cancer	0.000118	0.000407	CcSEcCtD
Niacin—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000118	0.000407	CcSEcCtD
Niacin—Chills—Methotrexate—lung cancer	0.000118	0.000406	CcSEcCtD
Niacin—Headache—Irinotecan—lung cancer	0.000117	0.000404	CcSEcCtD
Niacin—Insomnia—Docetaxel—lung cancer	0.000117	0.000404	CcSEcCtD
Niacin—Diarrhoea—Cisplatin—lung cancer	0.000116	0.000401	CcSEcCtD
Niacin—Paraesthesia—Docetaxel—lung cancer	0.000116	0.000401	CcSEcCtD
Niacin—Alopecia—Methotrexate—lung cancer	0.000116	0.0004	CcSEcCtD
Niacin—Vomiting—Gemcitabine—lung cancer	0.000116	0.0004	CcSEcCtD
Niacin—Dyspnoea—Docetaxel—lung cancer	0.000116	0.000398	CcSEcCtD
Niacin—Somnolence—Docetaxel—lung cancer	0.000115	0.000397	CcSEcCtD
Niacin—Rash—Gemcitabine—lung cancer	0.000115	0.000396	CcSEcCtD
Niacin—Dermatitis—Gemcitabine—lung cancer	0.000115	0.000396	CcSEcCtD
Niacin—Hypersensitivity—Etoposide—lung cancer	0.000115	0.000396	CcSEcCtD
Niacin—Erythema—Methotrexate—lung cancer	0.000114	0.000394	CcSEcCtD
Niacin—Malnutrition—Methotrexate—lung cancer	0.000114	0.000394	CcSEcCtD
Niacin—Haemoglobin—Doxorubicin—lung cancer	0.000114	0.000394	CcSEcCtD
Niacin—Headache—Gemcitabine—lung cancer	0.000114	0.000394	CcSEcCtD
Niacin—Rhinitis—Doxorubicin—lung cancer	0.000114	0.000393	CcSEcCtD
Niacin—Dyspepsia—Docetaxel—lung cancer	0.000114	0.000393	CcSEcCtD
Niacin—Hepatitis—Doxorubicin—lung cancer	0.000114	0.000392	CcSEcCtD
Niacin—Haemorrhage—Doxorubicin—lung cancer	0.000114	0.000392	CcSEcCtD
Niacin—Hypoaesthesia—Doxorubicin—lung cancer	0.000113	0.00039	CcSEcCtD
Niacin—Decreased appetite—Docetaxel—lung cancer	0.000113	0.000388	CcSEcCtD
Niacin—Hypersensitivity—Paclitaxel—lung cancer	0.000113	0.000388	CcSEcCtD
Niacin—Oedema peripheral—Doxorubicin—lung cancer	0.000112	0.000386	CcSEcCtD
Niacin—Gastrointestinal disorder—Docetaxel—lung cancer	0.000112	0.000385	CcSEcCtD
Niacin—Asthenia—Etoposide—lung cancer	0.000112	0.000385	CcSEcCtD
Niacin—Nausea—Irinotecan—lung cancer	0.000111	0.000383	CcSEcCtD
Niacin—Pain—Docetaxel—lung cancer	0.000111	0.000382	CcSEcCtD
Niacin—Pruritus—Etoposide—lung cancer	0.00011	0.00038	CcSEcCtD
Niacin—Visual impairment—Doxorubicin—lung cancer	0.00011	0.000378	CcSEcCtD
Niacin—Asthenia—Paclitaxel—lung cancer	0.00011	0.000378	CcSEcCtD
Niacin—Nausea—Gemcitabine—lung cancer	0.000108	0.000374	CcSEcCtD
Niacin—Vomiting—Cisplatin—lung cancer	0.000108	0.000373	CcSEcCtD
Niacin—Pruritus—Paclitaxel—lung cancer	0.000108	0.000372	CcSEcCtD
Niacin—Vision blurred—Methotrexate—lung cancer	0.000108	0.000371	CcSEcCtD
Niacin—Rash—Cisplatin—lung cancer	0.000107	0.00037	CcSEcCtD
Niacin—Dermatitis—Cisplatin—lung cancer	0.000107	0.000369	CcSEcCtD
Niacin—Diarrhoea—Etoposide—lung cancer	0.000107	0.000367	CcSEcCtD
Niacin—Eye disorder—Doxorubicin—lung cancer	0.000106	0.000366	CcSEcCtD
Niacin—Tinnitus—Doxorubicin—lung cancer	0.000106	0.000365	CcSEcCtD
Niacin—Gastrointestinal pain—Docetaxel—lung cancer	0.000106	0.000365	CcSEcCtD
Niacin—Flushing—Doxorubicin—lung cancer	0.000106	0.000364	CcSEcCtD
Niacin—Diarrhoea—Paclitaxel—lung cancer	0.000105	0.00036	CcSEcCtD
Niacin—Angiopathy—Doxorubicin—lung cancer	0.000103	0.000356	CcSEcCtD
Niacin—Dizziness—Etoposide—lung cancer	0.000103	0.000355	CcSEcCtD
Niacin—Vertigo—Methotrexate—lung cancer	0.000103	0.000354	CcSEcCtD
Niacin—Abdominal pain—Docetaxel—lung cancer	0.000102	0.000353	CcSEcCtD
Niacin—Body temperature increased—Docetaxel—lung cancer	0.000102	0.000353	CcSEcCtD
Niacin—Leukopenia—Methotrexate—lung cancer	0.000102	0.000353	CcSEcCtD
Niacin—Chills—Doxorubicin—lung cancer	0.000102	0.000352	CcSEcCtD
Niacin—Arrhythmia—Doxorubicin—lung cancer	0.000102	0.00035	CcSEcCtD
Niacin—Dizziness—Paclitaxel—lung cancer	0.000101	0.000348	CcSEcCtD
Niacin—Nausea—Cisplatin—lung cancer	0.000101	0.000348	CcSEcCtD
Niacin—Alopecia—Doxorubicin—lung cancer	0.000101	0.000346	CcSEcCtD
Niacin—Cough—Methotrexate—lung cancer	9.99e-05	0.000344	CcSEcCtD
Niacin—Vomiting—Etoposide—lung cancer	9.92e-05	0.000341	CcSEcCtD
Niacin—Malnutrition—Doxorubicin—lung cancer	9.91e-05	0.000341	CcSEcCtD
Niacin—Erythema—Doxorubicin—lung cancer	9.91e-05	0.000341	CcSEcCtD
Niacin—Rash—Etoposide—lung cancer	9.83e-05	0.000339	CcSEcCtD
Niacin—Dermatitis—Etoposide—lung cancer	9.82e-05	0.000338	CcSEcCtD
Niacin—Headache—Etoposide—lung cancer	9.77e-05	0.000336	CcSEcCtD
Niacin—Flatulence—Doxorubicin—lung cancer	9.77e-05	0.000336	CcSEcCtD
Niacin—Arthralgia—Methotrexate—lung cancer	9.74e-05	0.000336	CcSEcCtD
Niacin—Myalgia—Methotrexate—lung cancer	9.74e-05	0.000336	CcSEcCtD
Niacin—Tension—Doxorubicin—lung cancer	9.73e-05	0.000335	CcSEcCtD
Niacin—Vomiting—Paclitaxel—lung cancer	9.72e-05	0.000335	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	9.68e-05	0.000333	CcSEcCtD
Niacin—Rash—Paclitaxel—lung cancer	9.64e-05	0.000332	CcSEcCtD
Niacin—Dermatitis—Paclitaxel—lung cancer	9.63e-05	0.000332	CcSEcCtD
Niacin—Nervousness—Doxorubicin—lung cancer	9.63e-05	0.000331	CcSEcCtD
Niacin—Headache—Paclitaxel—lung cancer	9.58e-05	0.00033	CcSEcCtD
Niacin—Hypersensitivity—Docetaxel—lung cancer	9.55e-05	0.000329	CcSEcCtD
Niacin—Muscle spasms—Doxorubicin—lung cancer	9.53e-05	0.000328	CcSEcCtD
Niacin—Anaphylactic shock—Methotrexate—lung cancer	9.34e-05	0.000322	CcSEcCtD
Niacin—Vision blurred—Doxorubicin—lung cancer	9.34e-05	0.000322	CcSEcCtD
Niacin—Asthenia—Docetaxel—lung cancer	9.3e-05	0.00032	CcSEcCtD
Niacin—Nausea—Etoposide—lung cancer	9.26e-05	0.000319	CcSEcCtD
Niacin—Pruritus—Docetaxel—lung cancer	9.17e-05	0.000316	CcSEcCtD
Niacin—Nausea—Paclitaxel—lung cancer	9.08e-05	0.000313	CcSEcCtD
Niacin—Skin disorder—Methotrexate—lung cancer	9.07e-05	0.000312	CcSEcCtD
Niacin—Hyperhidrosis—Methotrexate—lung cancer	9.03e-05	0.000311	CcSEcCtD
Niacin—Vertigo—Doxorubicin—lung cancer	8.9e-05	0.000307	CcSEcCtD
Niacin—Anorexia—Methotrexate—lung cancer	8.9e-05	0.000307	CcSEcCtD
Niacin—Syncope—Doxorubicin—lung cancer	8.89e-05	0.000306	CcSEcCtD
Niacin—Leukopenia—Doxorubicin—lung cancer	8.87e-05	0.000305	CcSEcCtD
Niacin—Diarrhoea—Docetaxel—lung cancer	8.87e-05	0.000305	CcSEcCtD
Niacin—Palpitations—Doxorubicin—lung cancer	8.76e-05	0.000302	CcSEcCtD
Niacin—Hypotension—Methotrexate—lung cancer	8.73e-05	0.000301	CcSEcCtD
Niacin—Loss of consciousness—Doxorubicin—lung cancer	8.71e-05	0.0003	CcSEcCtD
Niacin—Cough—Doxorubicin—lung cancer	8.65e-05	0.000298	CcSEcCtD
Niacin—Dizziness—Docetaxel—lung cancer	8.57e-05	0.000295	CcSEcCtD
Niacin—Musculoskeletal discomfort—Methotrexate—lung cancer	8.51e-05	0.000293	CcSEcCtD
Niacin—Insomnia—Methotrexate—lung cancer	8.45e-05	0.000291	CcSEcCtD
Niacin—Arthralgia—Doxorubicin—lung cancer	8.44e-05	0.000291	CcSEcCtD
Niacin—Myalgia—Doxorubicin—lung cancer	8.44e-05	0.000291	CcSEcCtD
Niacin—Paraesthesia—Methotrexate—lung cancer	8.39e-05	0.000289	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	8.38e-05	0.000289	CcSEcCtD
Niacin—Dyspnoea—Methotrexate—lung cancer	8.33e-05	0.000287	CcSEcCtD
Niacin—Somnolence—Methotrexate—lung cancer	8.3e-05	0.000286	CcSEcCtD
Niacin—Dry mouth—Doxorubicin—lung cancer	8.25e-05	0.000284	CcSEcCtD
Niacin—Vomiting—Docetaxel—lung cancer	8.24e-05	0.000284	CcSEcCtD
Niacin—Dyspepsia—Methotrexate—lung cancer	8.22e-05	0.000283	CcSEcCtD
Niacin—Rash—Docetaxel—lung cancer	8.17e-05	0.000281	CcSEcCtD
Niacin—Dermatitis—Docetaxel—lung cancer	8.16e-05	0.000281	CcSEcCtD
Niacin—Decreased appetite—Methotrexate—lung cancer	8.12e-05	0.00028	CcSEcCtD
Niacin—Headache—Docetaxel—lung cancer	8.12e-05	0.00028	CcSEcCtD
Niacin—Anaphylactic shock—Doxorubicin—lung cancer	8.09e-05	0.000279	CcSEcCtD
Niacin—Oedema—Doxorubicin—lung cancer	8.09e-05	0.000279	CcSEcCtD
Niacin—Gastrointestinal disorder—Methotrexate—lung cancer	8.07e-05	0.000278	CcSEcCtD
Niacin—Pain—Methotrexate—lung cancer	7.99e-05	0.000275	CcSEcCtD
Niacin—Shock—Doxorubicin—lung cancer	7.96e-05	0.000274	CcSEcCtD
Niacin—Tachycardia—Doxorubicin—lung cancer	7.89e-05	0.000272	CcSEcCtD
Niacin—Skin disorder—Doxorubicin—lung cancer	7.86e-05	0.000271	CcSEcCtD
Niacin—Hyperhidrosis—Doxorubicin—lung cancer	7.82e-05	0.000269	CcSEcCtD
Niacin—Anorexia—Doxorubicin—lung cancer	7.71e-05	0.000265	CcSEcCtD
Niacin—Nausea—Docetaxel—lung cancer	7.7e-05	0.000265	CcSEcCtD
Niacin—Gastrointestinal pain—Methotrexate—lung cancer	7.64e-05	0.000263	CcSEcCtD
Niacin—Hypotension—Doxorubicin—lung cancer	7.56e-05	0.00026	CcSEcCtD
Niacin—Urticaria—Methotrexate—lung cancer	7.42e-05	0.000256	CcSEcCtD
Niacin—Abdominal pain—Methotrexate—lung cancer	7.38e-05	0.000254	CcSEcCtD
Niacin—Body temperature increased—Methotrexate—lung cancer	7.38e-05	0.000254	CcSEcCtD
Niacin—Musculoskeletal discomfort—Doxorubicin—lung cancer	7.37e-05	0.000254	CcSEcCtD
Niacin—Insomnia—Doxorubicin—lung cancer	7.32e-05	0.000252	CcSEcCtD
Niacin—Paraesthesia—Doxorubicin—lung cancer	7.26e-05	0.00025	CcSEcCtD
Niacin—Dyspnoea—Doxorubicin—lung cancer	7.21e-05	0.000248	CcSEcCtD
Niacin—Somnolence—Doxorubicin—lung cancer	7.19e-05	0.000248	CcSEcCtD
Niacin—Dyspepsia—Doxorubicin—lung cancer	7.12e-05	0.000245	CcSEcCtD
Niacin—Decreased appetite—Doxorubicin—lung cancer	7.03e-05	0.000242	CcSEcCtD
Niacin—Gastrointestinal disorder—Doxorubicin—lung cancer	6.98e-05	0.00024	CcSEcCtD
Niacin—Pain—Doxorubicin—lung cancer	6.92e-05	0.000238	CcSEcCtD
Niacin—Hypersensitivity—Methotrexate—lung cancer	6.88e-05	0.000237	CcSEcCtD
Niacin—Asthenia—Methotrexate—lung cancer	6.7e-05	0.000231	CcSEcCtD
Niacin—Gastrointestinal pain—Doxorubicin—lung cancer	6.61e-05	0.000228	CcSEcCtD
Niacin—Pruritus—Methotrexate—lung cancer	6.61e-05	0.000228	CcSEcCtD
Niacin—Urticaria—Doxorubicin—lung cancer	6.43e-05	0.000221	CcSEcCtD
Niacin—Abdominal pain—Doxorubicin—lung cancer	6.39e-05	0.00022	CcSEcCtD
Niacin—Body temperature increased—Doxorubicin—lung cancer	6.39e-05	0.00022	CcSEcCtD
Niacin—Diarrhoea—Methotrexate—lung cancer	6.39e-05	0.00022	CcSEcCtD
Niacin—Dizziness—Methotrexate—lung cancer	6.18e-05	0.000213	CcSEcCtD
Niacin—Hypersensitivity—Doxorubicin—lung cancer	5.96e-05	0.000205	CcSEcCtD
Niacin—Vomiting—Methotrexate—lung cancer	5.94e-05	0.000204	CcSEcCtD
Niacin—Rash—Methotrexate—lung cancer	5.89e-05	0.000203	CcSEcCtD
Niacin—Dermatitis—Methotrexate—lung cancer	5.88e-05	0.000203	CcSEcCtD
Niacin—Headache—Methotrexate—lung cancer	5.85e-05	0.000201	CcSEcCtD
Niacin—Asthenia—Doxorubicin—lung cancer	5.8e-05	0.0002	CcSEcCtD
Niacin—Pruritus—Doxorubicin—lung cancer	5.72e-05	0.000197	CcSEcCtD
Niacin—Nausea—Methotrexate—lung cancer	5.55e-05	0.000191	CcSEcCtD
Niacin—Diarrhoea—Doxorubicin—lung cancer	5.53e-05	0.000191	CcSEcCtD
Niacin—Dizziness—Doxorubicin—lung cancer	5.35e-05	0.000184	CcSEcCtD
Niacin—Vomiting—Doxorubicin—lung cancer	5.14e-05	0.000177	CcSEcCtD
Niacin—Rash—Doxorubicin—lung cancer	5.1e-05	0.000176	CcSEcCtD
Niacin—Dermatitis—Doxorubicin—lung cancer	5.1e-05	0.000175	CcSEcCtD
Niacin—Headache—Doxorubicin—lung cancer	5.07e-05	0.000174	CcSEcCtD
Niacin—SLC16A3—Metabolism—GSTP1—lung cancer	4.91e-05	0.000227	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—MAPK3—lung cancer	4.9e-05	0.000226	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—APOA1—lung cancer	4.89e-05	0.000226	CbGpPWpGaD
Niacin—QPRT—Metabolism—PTEN—lung cancer	4.89e-05	0.000226	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—NRAS—lung cancer	4.88e-05	0.000226	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—POMC—lung cancer	4.87e-05	0.000225	CbGpPWpGaD
Niacin—QPRT—Disease—MYC—lung cancer	4.85e-05	0.000224	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—BRAF—lung cancer	4.81e-05	0.000222	CbGpPWpGaD
Niacin—Nausea—Doxorubicin—lung cancer	4.8e-05	0.000165	CcSEcCtD
Niacin—SLC16A1—Metabolism—AKR1C1—lung cancer	4.78e-05	0.000221	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CAT—lung cancer	4.78e-05	0.000221	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAP2K1—lung cancer	4.77e-05	0.000221	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—APOA1—lung cancer	4.76e-05	0.00022	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—AVP—lung cancer	4.76e-05	0.00022	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6R—lung cancer	4.75e-05	0.00022	CbGpPWpGaD
Niacin—QPRT—Disease—EGFR—lung cancer	4.74e-05	0.000219	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CD—lung cancer	4.74e-05	0.000219	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CREBBP—lung cancer	4.74e-05	0.000219	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—PIK3CA—lung cancer	4.7e-05	0.000217	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—MAPK3—lung cancer	4.68e-05	0.000216	CbGpPWpGaD
Niacin—QPRT—Metabolism—EP300—lung cancer	4.66e-05	0.000215	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—EGFR—lung cancer	4.66e-05	0.000215	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ABCB1—lung cancer	4.65e-05	0.000215	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—KRAS—lung cancer	4.64e-05	0.000215	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—UGT1A1—lung cancer	4.64e-05	0.000214	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—lung cancer	4.61e-05	0.000213	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—TYMS—lung cancer	4.57e-05	0.000211	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTEN—lung cancer	4.54e-05	0.00021	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAP2K1—lung cancer	4.53e-05	0.000209	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTM1—lung cancer	4.51e-05	0.000209	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CD—lung cancer	4.5e-05	0.000208	CbGpPWpGaD
Niacin—QPRT—Disease—KRAS—lung cancer	4.48e-05	0.000207	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GNG11—lung cancer	4.47e-05	0.000207	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CG—lung cancer	4.46e-05	0.000206	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—PIK3CA—lung cancer	4.45e-05	0.000206	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—EGF—lung cancer	4.41e-05	0.000204	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—KRAS—lung cancer	4.4e-05	0.000203	CbGpPWpGaD
Niacin—NNMT—Metabolism—EP300—lung cancer	4.33e-05	0.0002	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTP1—lung cancer	4.32e-05	0.0002	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP1A1—lung cancer	4.28e-05	0.000198	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PIK3CA—lung cancer	4.27e-05	0.000197	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTP1—lung cancer	4.26e-05	0.000197	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALDOA—lung cancer	4.26e-05	0.000197	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MDM2—lung cancer	4.25e-05	0.000196	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ERCC2—lung cancer	4.24e-05	0.000196	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—RAF1—lung cancer	4.23e-05	0.000196	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—APOA1—lung cancer	4.23e-05	0.000196	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—KRAS—lung cancer	4.2e-05	0.000194	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ERBB2—lung cancer	4.19e-05	0.000194	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—CREBBP—lung cancer	4.14e-05	0.000191	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NCOA3—lung cancer	4.14e-05	0.000191	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CB—lung cancer	4.13e-05	0.000191	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MTOR—lung cancer	4.13e-05	0.000191	CbGpPWpGaD
Niacin—QPRT—Disease—PIK3CA—lung cancer	4.12e-05	0.00019	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CA—lung cancer	4.04e-05	0.000187	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—CREBBP—lung cancer	4.03e-05	0.000186	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MDM2—lung cancer	4.03e-05	0.000186	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ABCG2—lung cancer	4.02e-05	0.000186	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ADCY1—lung cancer	4.02e-05	0.000186	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RAF1—lung cancer	4.01e-05	0.000186	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCL8—lung cancer	3.97e-05	0.000184	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ERBB2—lung cancer	3.97e-05	0.000184	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTM1—lung cancer	3.97e-05	0.000184	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—HRAS—lung cancer	3.95e-05	0.000182	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ENO2—lung cancer	3.94e-05	0.000182	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HPGDS—lung cancer	3.94e-05	0.000182	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CD—lung cancer	3.92e-05	0.000181	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPP2R1B—lung cancer	3.92e-05	0.000181	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MTOR—lung cancer	3.92e-05	0.000181	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CB—lung cancer	3.92e-05	0.000181	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTM1—lung cancer	3.92e-05	0.000181	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ALB—lung cancer	3.87e-05	0.000179	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CA—lung cancer	3.86e-05	0.000178	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AKT1—lung cancer	3.84e-05	0.000177	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTT1—lung cancer	3.83e-05	0.000177	CbGpPWpGaD
Niacin—QPRT—Disease—HRAS—lung cancer	3.81e-05	0.000176	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CASP3—lung cancer	3.8e-05	0.000176	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL2—lung cancer	3.8e-05	0.000175	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP2A6—lung cancer	3.78e-05	0.000175	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GCLC—lung cancer	3.78e-05	0.000175	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL6—lung cancer	3.78e-05	0.000175	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ALB—lung cancer	3.77e-05	0.000174	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CXCL8—lung cancer	3.77e-05	0.000174	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP1A1—lung cancer	3.76e-05	0.000174	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—HRAS—lung cancer	3.74e-05	0.000173	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—lung cancer	3.73e-05	0.000173	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP1A1—lung cancer	3.71e-05	0.000172	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCND1—lung cancer	3.7e-05	0.000171	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—JUN—lung cancer	3.69e-05	0.000171	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—APOA1—lung cancer	3.67e-05	0.00017	CbGpPWpGaD
Niacin—QPRT—Disease—IL6—lung cancer	3.65e-05	0.000169	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—APOA1—lung cancer	3.64e-05	0.000168	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AKT1—lung cancer	3.64e-05	0.000168	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CASP3—lung cancer	3.6e-05	0.000167	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL2—lung cancer	3.6e-05	0.000166	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MMP9—lung cancer	3.59e-05	0.000166	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ENO1—lung cancer	3.59e-05	0.000166	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—CREBBP—lung cancer	3.58e-05	0.000166	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL6—lung cancer	3.58e-05	0.000166	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN1A—lung cancer	3.58e-05	0.000166	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—HRAS—lung cancer	3.57e-05	0.000165	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTEN—lung cancer	3.57e-05	0.000165	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCND1—lung cancer	3.51e-05	0.000162	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—RAF1—lung cancer	3.5e-05	0.000162	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—JUN—lung cancer	3.5e-05	0.000162	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AKT1—lung cancer	3.48e-05	0.000161	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CA—lung cancer	3.45e-05	0.000159	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CB—lung cancer	3.42e-05	0.000158	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—RAF1—lung cancer	3.41e-05	0.000158	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EP300—lung cancer	3.41e-05	0.000157	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP9—lung cancer	3.41e-05	0.000157	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1A—lung cancer	3.39e-05	0.000157	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTEN—lung cancer	3.39e-05	0.000157	CbGpPWpGaD
Niacin—QPRT—Disease—AKT1—lung cancer	3.36e-05	0.000155	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ALB—lung cancer	3.35e-05	0.000155	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CG—lung cancer	3.35e-05	0.000155	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SRC—lung cancer	3.31e-05	0.000153	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—COL4A3BP—lung cancer	3.31e-05	0.000153	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AZIN2—lung cancer	3.31e-05	0.000153	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AKT1—lung cancer	3.3e-05	0.000153	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EP300—lung cancer	3.23e-05	0.000149	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—lung cancer	3.23e-05	0.000149	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP2E1—lung cancer	3.22e-05	0.000149	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CA—lung cancer	3.21e-05	0.000148	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—STAT3—lung cancer	3.19e-05	0.000148	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—POMC—lung cancer	3.19e-05	0.000147	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NRAS—lung cancer	3.19e-05	0.000147	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NQO1—lung cancer	3.18e-05	0.000147	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—AKT1—lung cancer	3.15e-05	0.000146	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IL2—lung cancer	3.14e-05	0.000145	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SRC—lung cancer	3.14e-05	0.000145	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CREBBP—lung cancer	3.11e-05	0.000144	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—CREBBP—lung cancer	3.08e-05	0.000142	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—lung cancer	3.06e-05	0.000141	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAPK3—lung cancer	3.05e-05	0.000141	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—RAF1—lung cancer	3.03e-05	0.00014	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—STAT3—lung cancer	3.03e-05	0.00014	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NRAS—lung cancer	3.02e-05	0.00014	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MYC—lung cancer	2.97e-05	0.000137	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CD—lung cancer	2.95e-05	0.000136	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ALB—lung cancer	2.91e-05	0.000134	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGFR—lung cancer	2.9e-05	0.000134	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAPK3—lung cancer	2.89e-05	0.000134	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ALB—lung cancer	2.88e-05	0.000133	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—STK11—lung cancer	2.87e-05	0.000133	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—EP300—lung cancer	2.82e-05	0.00013	CbGpPWpGaD
Niacin—QPRT—Metabolism—AKT1—lung cancer	2.82e-05	0.00013	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ATP5H—lung cancer	2.81e-05	0.00013	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—lung cancer	2.81e-05	0.00013	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—POMC—lung cancer	2.81e-05	0.00013	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGFR—lung cancer	2.75e-05	0.000127	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KRAS—lung cancer	2.74e-05	0.000127	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SRC—lung cancer	2.74e-05	0.000127	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—lung cancer	2.67e-05	0.000123	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTP1—lung cancer	2.65e-05	0.000123	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NRAS—lung cancer	2.64e-05	0.000122	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKT1—lung cancer	2.62e-05	0.000121	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—RAF1—lung cancer	2.61e-05	0.000121	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KRAS—lung cancer	2.6e-05	0.00012	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CAT—lung cancer	2.58e-05	0.000119	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CB—lung cancer	2.57e-05	0.000119	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS2—lung cancer	2.54e-05	0.000118	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—MAPK3—lung cancer	2.53e-05	0.000117	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CA—lung cancer	2.52e-05	0.000116	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ABCB1—lung cancer	2.51e-05	0.000116	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PLBD1—lung cancer	2.51e-05	0.000116	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TYMS—lung cancer	2.47e-05	0.000114	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—lung cancer	2.44e-05	0.000113	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTM1—lung cancer	2.44e-05	0.000113	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CA—lung cancer	2.39e-05	0.00011	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HRAS—lung cancer	2.33e-05	0.000108	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—lung cancer	2.31e-05	0.000107	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP1A1—lung cancer	2.31e-05	0.000107	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HSD17B10—lung cancer	2.29e-05	0.000106	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ERCC2—lung cancer	2.29e-05	0.000106	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KRAS—lung cancer	2.27e-05	0.000105	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL6—lung cancer	2.23e-05	0.000103	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTEN—lung cancer	2.22e-05	0.000103	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HRAS—lung cancer	2.21e-05	0.000102	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CKB—lung cancer	2.13e-05	9.86e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—EP300—lung cancer	2.12e-05	9.78e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6—lung cancer	2.12e-05	9.78e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CA—lung cancer	2.08e-05	9.64e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT1—lung cancer	2.06e-05	9.52e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—lung cancer	2.02e-05	9.32e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTM2—lung cancer	2.01e-05	9.27e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CNDP2—lung cancer	2.01e-05	9.27e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—APOA1—lung cancer	1.98e-05	9.16e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT1—lung cancer	1.95e-05	9.02e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTMR3—lung cancer	1.95e-05	9.02e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HRAS—lung cancer	1.93e-05	8.92e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PGAM1—lung cancer	1.9e-05	8.79e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP2A7—lung cancer	1.81e-05	8.38e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CG—lung cancer	1.81e-05	8.37e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SDC4—lung cancer	1.77e-05	8.21e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—POMC—lung cancer	1.72e-05	7.96e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT1—lung cancer	1.7e-05	7.87e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CREBBP—lung cancer	1.68e-05	7.76e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—RRM1—lung cancer	1.62e-05	7.47e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTA3—lung cancer	1.62e-05	7.47e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CD—lung cancer	1.59e-05	7.35e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALB—lung cancer	1.57e-05	7.26e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CA—lung cancer	1.57e-05	7.24e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—B4GALT5—lung cancer	1.52e-05	7.03e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTA4—lung cancer	1.48e-05	6.84e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTA2—lung cancer	1.44e-05	6.66e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTA1—lung cancer	1.39e-05	6.43e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CB—lung cancer	1.39e-05	6.41e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCC3—lung cancer	1.37e-05	6.35e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS2—lung cancer	1.37e-05	6.35e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKR1C1—lung cancer	1.33e-05	6.15e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—UGT1A1—lung cancer	1.29e-05	5.97e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKT1—lung cancer	1.28e-05	5.91e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GNG11—lung cancer	1.25e-05	5.76e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTEN—lung cancer	1.2e-05	5.54e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALDOA—lung cancer	1.19e-05	5.49e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NCOA3—lung cancer	1.15e-05	5.33e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—EP300—lung cancer	1.14e-05	5.28e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ADCY1—lung cancer	1.12e-05	5.18e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCG2—lung cancer	1.12e-05	5.18e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HPGDS—lung cancer	1.1e-05	5.08e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ENO2—lung cancer	1.1e-05	5.08e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.09e-05	5.05e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTT1—lung cancer	1.07e-05	4.93e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GCLC—lung cancer	1.05e-05	4.87e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP2A6—lung cancer	1.05e-05	4.87e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ENO1—lung cancer	9.99e-06	4.62e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP2E1—lung cancer	8.96e-06	4.14e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NQO1—lung cancer	8.86e-06	4.09e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CA—lung cancer	8.45e-06	3.91e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—STK11—lung cancer	7.98e-06	3.69e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTP1—lung cancer	7.39e-06	3.42e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CAT—lung cancer	7.19e-06	3.32e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCB1—lung cancer	6.99e-06	3.23e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKT1—lung cancer	6.91e-06	3.19e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TYMS—lung cancer	6.87e-06	3.18e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTM1—lung cancer	6.79e-06	3.14e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP1A1—lung cancer	6.44e-06	2.98e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ERCC2—lung cancer	6.38e-06	2.95e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APOA1—lung cancer	5.52e-06	2.55e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CG—lung cancer	5.04e-06	2.33e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—POMC—lung cancer	4.8e-06	2.22e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CREBBP—lung cancer	4.67e-06	2.16e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CD—lung cancer	4.43e-06	2.05e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALB—lung cancer	4.37e-06	2.02e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CB—lung cancer	3.86e-06	1.79e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS2—lung cancer	3.83e-06	1.77e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTEN—lung cancer	3.34e-06	1.54e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—EP300—lung cancer	3.18e-06	1.47e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CA—lung cancer	2.35e-06	1.09e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKT1—lung cancer	1.92e-06	8.89e-06	CbGpPWpGaD
